A Phase II/III, Multisite, Randomized Master Protocol for a Global Trial of BNT327 in Combination With Chemotherapy and Other Investigational Agents in First-line Non-small Cell Lung Cancer

16718BNT327-06-NCT06712316OpenA Phase II/III, Multisite, Randomized Master Protocol for a Global Trial of BNT327 in Combination With Chemotherapy and Other Investigational Agents in First-line Non-small Cell Lung CancerBNT327-06NCT06712316IndustrialAdultTreatmentII/IIIOtherLiu, StephenGeorgetown University Medical Center : Matt Hayhurst; Lombardi Comprehensive Cancer Center : Matt Hayhurst; Medstar Washington Hospital CenterThoracic/CNS/H&N/ThyroidOncology GroupLombardi Comprehensive Cancer Center (LCCC); MHRI Washington Cancer Institute; Oncology PFS16691Matt HayhurstMatt Hayhurstmh2340@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>